Poster Tours
Share |

WPC 2016 Poster Tour Schedule

Poster tours will start promptly at 5:15 PM on Wednesday and Thursday evenings. Presenters of the following featured posters will be present during poster tours to explain their work. Tour sign-up is required (see sheets in Exhibit Hall B). Meeting point at first poster of tour at 5:15 PM.


Wednesday, September 21, 2016 at 5:15 PM 


Tour #1 

Guide: Thomas Gasser 


  1. P.01.08: Polychlorinated biphenyls (PCBs) are associated with Parkinson’s disease risk in two populations
    Author: Samuel Goldman

  2. P.01.12: Variable frequency of LRRK2 mutations in Latin America, a case of ancestry
    Author: Ignacio Mata

  3. P01.13: The Roles of Diet, Exercise, & Supplements in Parkinson’s Disease Progression
    Author: Laurie Mischley

  4. P01.15: Association of brain organochlorines with Lewy pathology
    Author: G. Webster Ross

  5. P01.16: Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Penetrance of LRRK2 Parkinson’s Disease (PD)
    Author: Caroline Tanner

  6. LBP2: Association between tobacco smoking and serum haptoglobin concentration in Parkinson disease cases and controls: effect modification by haptoglobin phenotype
    Author: Paola Costa-Mallen

Tour #2

Guide: Yoshikuni Mizuno


  1. P02.05: Tools and technologies for the production of midbrain dopaminergic neurons from human pluripotent stem cells
    Author: Nicola Drummond

  2. P02.10: The neuroprotective action of UBP310 is dependent upon multiple kainate receptor subunits
    Author: Sandy Stayte

  3. P03.04: Inhibition of membrane-induced aSyn aggregation: a strategy to interfere with alpha-synuclein neurotoxicity in Parkinson’s disease
    Author: Jean-Christophe Rochet

  4. P20.04: Neuroprotective potential of transcription factors Lmx1a and Lmx1b in mouse models of Parkinson's disease
    Author: Hélène Doucet-Beaupré

  5. LBP3: Melanoma-linked MC1R supports dopaminergic neuron survival
    Author: Xiqun Chen

Tour #3

Guide: Malu Tansey


  1. P06.10: Understanding the Pathogenesis of Parkinson's Disease Through Genetic Modifiers
    Author: Marie Davis

  2. P06.11: KH176 as a novel disease-modifying therapeutic for Parkinson's Disease
    Author: Ria de Haas

  3. P06.12: Diffuse Brain Injury in Swine causes Plasmalemmal Dysruption and α-Synuclein Over-expression in the Substantia Nigra
    Author: John Duda (presented by Carolyn Keating)

  4. P06.16: Functional interaction of the Parkinson´s disease risk factor RIT2 with alpha-synuclein
    Author: Mattia Volta
  5. Lipid accumulation in Gaucher disease promotes α-synuclein pathology in Parkinson’s disease
    Author: Yumiko Taguchi

  6. P06.20: Reverse genetics screening reveals LRRK2 phosphorylation regulators
    Author: Jean-Marc Taymans

Tour #4

Guide: Soania Mathur


  1. P13.01: Enteral feeding using Duopa PEG-J - A case report
    Author: Andréane Bernier

  2. P13.03: Feasibility of peer coaching to increase physical activity in people with Parkinson disease
    Author: Cristina Colon-Semenza

  3. P13.04: Parkinson’s specific HI-FIT group exercise class: Developing and maintaining a successful class
    Author: Amanda Elliott

  4. P13.09: MOVE IT!™ EXERCISE CLUB – Real Time Streaming Exercise Program:  Maximizing technology to deliver an online Parkinson specific exercise program provided by Parkinson trained exercise professionals.
    Author: Judy Talley

  5. P13.13: Transforming People with Parkinson's Physically, Emotionally and Socially through Free Parkinson's Focused Fitness Program
    Author: Nina Mosier

  6. P13.14: Rhythmic exercise: A 5 year followup study in Nirway
    Author: Audun Myskja


Tour #5

Guide: Peter Fletcher


  1. P14.03: Mucuna pruriens product standardization and Indian ethnobotanical analysis
    Author: Tanya Denne

  2. P14.07: Dancing with Parkinson’s YYC: A community-based dance program improves functional daily activities in people with Parkinson’s disease.
    Author: Afra Foroud

  3. P14.14: Moving Through Glass: Exploring augmented reality technology for people with Parkinson's
    Author: David Leventhal

  4. P14.15: Complementary Therapies in Parkinson's Disease
    Author: Sarah Donley

  5. P14.17: Introducing Munira – An innovative mobile app utilizing rhythmic music as a novel therapeutic approach to dementia
    Author: Ayush Noori

  6. Parkinson’s Inpatient Quality Initiative (PIQI): A Retrospective Review.
    Author: Deepak Gupta


Tour #6

Guide: Lynn Rochester


  1. P33.26: Increased access to training in a Parkinson-specific rehabilitation approach through Online learning
    Author: Cynthia Fox

  2. P33.28: Yearly periods of challenging balance training to prevent decline in gait and balance.
    Author: Erika Franzén

  3. P33.57: Allied health utilization variability and outcomes for people with Parkinson’s disease: National Parkinson Foundation Quality Improvement Initiative (NPF-QII) data
    Author: Miriam Rafferty

  4. P33.58: Global implementation of efficacious voice treatment for Parkinson disease: LSVT LOUD : Germany®
    Author: Lorraine Ramig

  5. P33.66: Effects of a physical rehabilitation program with cognitive challenge for Freezing of Gait - A pilot study
    Author: Katrijn Smulders

  6. P33.67: Repetitive TMS for Parkinson’s Disease Rehabilitation: Differential Clinical Outcomes from a Randomized Trial
    Author: Alessandro DiRocco


Tour #7

Guide: Alice Templin


  1. P33.10: Group Speech Therapy Programs for People with Parkinson’s
    Author: Jennifer Cody

  2. P33.14: Eliminating handicaps: A binocular view of therapy
    Author: Jennifer Davis

  3. P33.33: Use of the SpeechVive device improves communication in people with Parkinson’s disease
    Author: Jessica Huber

  4. P33.36: The LSVT BIG Intervention in Clients with Parkinson’s disease: A Systematic Review
    Author: Dennis Klima

  5. P33.55: A comparison of the effect of multi-modal sensorimotor agility training on functional outcomes measures in individuals with atypical parkinsonism versus idiopathic Parkinson’s disease: A retrospective observational case-control study.
    Author: Catherine Printz

  6. P33.61: The profile of individuals with Parkinson’s disease referred for allied health services:  National Parkinson Foundation (NPF) QII Study
    Author: Angela Roberts

  7. P33.68: Visuo-cognition in gait in Parkinson’s disease: response to visual cues
    Author: Sam Stuart


Tour #8

Guide: Ronald Pfeiffer


  1. P24.02: Economic burden in advanced Parkinson’s disease patients uncontrolled on oral medications
    Author: Yash Jalundhwala

  2. P24.03: Identification of clinical and genetic predictors of Parkinson’s disease progression via Bayesian machine learning
    Author: Jeanne Latourelle

  3. P24.04: Predictors of dependency in Parkinson's disease
    Author: Angus Macleod

  4. P24.05: A disease specific exercise approach in independent community dwellers with Parkinson’s Disease: A pilot study
    Author: Valerie Carter

  5. P25.01: Parkinson symptoms list
    Author: David Bunch

  6. P26.05: Impact of telephone intervention service provided at a community-based Geriatrics Clinic for Parkinson’s: an observational study
    Author: Greta Mah

Tour #9

Guide: Joseph Freidman


  1. P26.08: The effect of Dopaminergic therapy on Stimulus-response learning and decision-making in Parkinson’s disease using 3T fMRI
    Author: Nole Hiebert

  2. P26.13: Large-scale Exploratory Analysis of Genetic Risk Factors for Cognitive Impairment in Parkinson’s Disease
    Author: Ignacio Mata

  3. P26.14: Gait at diagnosis, rather than cognition, predicts cognitive decline over three years in Parkinson’s disease
    Author: Rosie Morris

  4. P26.18: SYN120, a Dual 5-HT6/5-HT2A Antagonist, for Parkinson’s disease dementia (PDD) (SYNAPSE study): Study Design and Partial Blinded Baseline Data
    Author: Lindsay Pothier & Daniel Weintraub

  5. P27.03: Neuroinflammation in Prediagnostic Parkinson Disease: A Multitracer Pet Study of Idiopathic REM Sleep Behaviour Disorder Patients
    Author: Morten Gersel Stokholm

  6. P27.05: Differences between actual and perceived treatment groups in a double-blind placebo trial of acupuncture for fatigue in Parkinson's disease
    Author: Benzi Kluger

Tour #10

Guide: Ryuji Kaji


  1. P31.04: Five-year’s of levodopa-carbidopa intestinal gel treatment: safety and efficacy from an open-label phase 3 study in advanced Parkinson’s disease patients
    Author: Lars Bergmann (presented by Krai Chatamra)

  2. P31.05: Impact of droxidopa on symptoms, functionality, and health-related quality of life at 1 month following treatment initiation in a prospective study of patients with neurogenic orthostatic hypotension
    Author: Steven Kymes

  3. P31.14: A successful quality improvement process for improving timely levodopa administration in the hospital
    Author: Martha Nance

  4. P31.15: Levodopa-carbidopa intestinal gel in routine care of advanced Parkinson’s disease patients: final long-term efficacy results on motor complications from the GLORIA registry
    Author: Lars Bergmann

  5. P31.17: Simpler prescribing patterns are associated with a lower rate of falls.
    Author: Peter Schmidt

  6. P31.21: Individual levodopa dosing suggestions based on a single dose test
    Author: Ilias Thomas


Tour #11

Guide: Ken Aidekman


  1. P38.03: A New perspective of parkinson People - A photographic Exhibition
    Author: Sandra Elms

  2. P38.04: How are we going to tell the children? An overview and review of the Children's literature about Parkinson's disease.
    Author: Adele Hensley

  3. P38.07: "A Learning Community for Nursing Faculty: Dissemination and the Discovery of Caring for People Living with Parkinson's Disease"
    Author: Margaret McCormick

  4. P38.08: Improving Nursing Education on Parkinson's Disease
    Author: Gwyn Vernon

  5. P38.09: The PD Buddy Outreach Program – The Student Perspective
    Author: Kathrin LaFaver


Tour #12

Guide: Rebecca Miller


  1. P40.03: Is social health associated with Parkinson’s disease severity score?
    Author: Rachel Bennett

  2. P40.05: The PD Buddy Outreach Program – The Patient Perspective
    Author: Denise Cumberland

  3. P40.12: Tips and Tools for maintaining improvements in communication, mobility, and activities of daily living following LSVT LOUD® and LSVT BIG®
    Author: Laura Guse

  4. P40.34: Music Matters Choral Initiative: A Research and Action Project involving PD Choirs in Philadelphia and Baltimore
    Author: Marjorie Samoff

  5. LBP36: Imagine yourself then, imagine yourself now with Parkinson’s disease
    Author: Frank Church

  6. LBP40: Education/Outreach Program: Get Excited and Move (GEM) Savannah
    Author: Michael Cohen (presented by Sarah Bernzott)

Tour #13

Guide: John Dean


  1. P37.13: Quantification of Parkinson’s disease motor functions using wearable sensors
    Author: Mevludin Memedi

  2. P37.20: Tremor Severity Estimation Using Liftware Instrumented Eating Utensil
    Author: Sarah Wang

  3. P37.21: Development and evaluation of a social robot to assist in a medication management task
    Author: Jason Wilson


Thursday, September 22nd at 5:15 PM 


Tour # 14

Guide: Etienne Hirsch


  1. P01.03: Air pollution and Parkinson’s disease: mechanisms of diesel exhaust neuronal toxicity
    Author: Lisa Barnhill

  2. P01.07: GBA Mutations and the E326K Polymorphism are Associated with Faster Rate of Motor and Cognitive Progression in Parkinson Disease
    Author: Marie Davis

  3. P01.14: NFE2L2, PPARGC1α, and Oxidative Stress in Parkinson’s Disease Susceptibility and Progression
    Author: Kimberly Paul (presented by Cynthia Custers)

  4. P10.06: Optogenetic activation of striatal cholinergic interneurons or D1 medium spiny neurons regulates L-dopa-induced dyskinesias
    Author: Maryka Quik

  5. P10.08: Kinematic versus Neural triggered Adaptive DBS in a tremor dominant Parkinson’s disease patient
    Author: Helen Bronte-Stewart

Tour #15

Guide: Nicole Calakos


  1. P04.02: Neuroinflammation Parallels α-synuclein Accumulation and Precedes Nigral Degeneration Induced by Intrastriatal Injection of Preformed α-synuclein Fibrils
    Author: Megan Duffy

  2. P04.06: Influenza vaccine or Oseltamivir (Tamiflu®) can protect against microglial activation and a subsequent increase in oxidative stress susceptibility of dopaminergic neurons in the substantia nigra following infection with the non-neurotropic H1N1 influenza virus.
    Author: Richard Smeyne

  3. P04.07: Do PINK1 and Parkin influence the accumulation of mitochondrial DNA mutations in somatic tissues?
    Author: Colby Samstag

  4. P07.03: Striatal cholinergic interneurons expressing calretinin are numerically increased in parkinsonian monkeys
    Author: Martin Parent

  5. LBP10: M4 muscarinic receptor activity opposes D1 dopamine receptor-evoked GABA release and motor activity in the SNr: Implications for M4 antagonists as a treatment for movement disorders
    Author: Mark Moehle

Tour #16 

Guide: Roger Barker


  1. P06.05: Assessment of olfactory dysfunction in an inducible mouse model of α-synucleinopathy via multi-modality imaging
    Author: Elodie Brison

  2. P06.14: Targeting soluble TNF with XPro1595 to ameliorate motor and non-motor symptoms in a progressive non-human primate model of Parkinson’s disease
    Author: Valerie Joers

  3. P06.21: PD-like pathology triggered by α-synuclein overexpression in the dorsal motor nucleus of the vagus nerve
    Author: Ayse Ulusoy

  4. P06.22: Increased power of sleep spindle oscillations in the LRRK2 mouse model of Parkinson’s disease
    Author: Jean-Paul Wiegand

  5. P08.02: Gene Therapy Blockade of Dorsal Striatal p11 Improves Motor Function and Dyskinesia in Parkinsonian Mice
    Author: Roberta Marongiu

Tour #17

Guide: Lucie LaChance


  1. P21.03: Gait, balance and mobility in Parkinson's disease: Improvements after use of a DVD providing training in Alexander Technique
    Author: Bill Connington

  2. P21.05: Thinking in Action: Alexander Technique for Parkinson’s disease
    Author: Candace Cox

  3. P21.06: Nursing advocacy in assessment of the Parkinson's patient in acute and outpatient urgent care: Impact on health and quality of life
    Author: Mary Lou De Natale

  4. P21.08: Alexander Technique for Parkinson's: An initiative of The Poise Project
    Author: Monika Gross

  5. P21.09: Balancing medication with self analysis
    Author: Jari Hämäläinen

  6. P21.10: Staying Connected to Veterans with Deep Brain Stimulation
    Author: Miriam Hirsch

  7. P21.11: INSIDE SCOOP!™ - SHARING COLLECTIVE WISDOM:  Use of an online searchable database of tips that maximize self-efficacy and reduce isolation for people with PD and Care Partners.
    Author: Judy Talley & Sarah Jones

Tour #18

Guide: Anne-Louise Lafontaine


  1. P13.02: The impact of a 6-month Dance for Parkinson’s program on physical function and well-being: A mixed methods pilot study
    Author: Sandra Brauer

  2. P13.08: Use it or lose it: A Comparison of Forms of Exercise in Progression of Parkinson’s Disease
    Author: Kasey Holland

  3. P13.10: A program evaluation of a patient to participant, rehab to wellness program for persons with Parkinson’s Disease: bridging the gap between illness and wellness.
    Author: Erin Keefer

  4. P13.17: A clinical trial of a ketogenic diet as treatment of Parkinson' s disease
    Author: Richard Rosenbaum

  5. P13.18: Forging neuronal circuitry through the practice of yoga, meditation and Dance for Parkinson's.
    Author: Elizabeth Ruinard

  6. P13.21: Determinants of Physical Activity in Persons with Parkinson’s Disease
    Author: Andrew Zaman

  7. P13.22: Nordic walking enhances gait power profiles at the knee joint in Parkinson’s disease
    Author: Lei Zhou

Tour #19

Guide: Maria Barretto


  1. P19.01: Pay it forward: creating a donation-based funding model where no patient is denied therapy services based on insurance or financial limitations
    Author: Samantha Elandary

  2. P19.04: Multidisciplinary capacity building module for rehabilitation and care of Parkinson’s in India
    Author: Navaz Irani

  3. P22.02: Redefining social work for Parkinson’s: the development of a new model of care for specialized, comprehensive support in the clinic, community and home
    Author: Amy Lemen

  4. P23.22: Non motor symptoms dominant subtypes in PD: Analysis of 264 cases.
    Author: Thadshani Rajah (presented by Anna Sauerbier)

  5. P23.33: Attenuation of hyperalgesia responses via the modulation of 5-HT signaling in the rostral ventromedial medulla and spinal cord in a 6-OHDA-induced rat model of Parkinson’s disease
    Author: Fen Wang

  6. P32.06: Can Living Micro-Tissue Engineered Axonal Tracts Reconstruct the Nigrostriatal Pathway in PD?
    Author: John Duda

  7. LBP19: Breaking the News: An Ethical Approach to Telling Family, Friends, and Co-workers About Your YOPD Diagnosis
    Author: Lisa Garvey

Tour #20

Guide: Caroline Tanner


  1. P35.02: Stable levodopa plasma levels with ND0612 (levodopa/carbidopa for subcutaneous infusion) in Parkinson’s disease (PD) patients with motor fluctuations
    Author: Sheila Oren

  2. P35.05: AFF008A: Successful boosting of an existing PD01A-induced immune response. Safety & immunological analysis of an AFFITOPE®-based vaccine approach (PD01A) for the treatment of patients with early stage Parkinson’s Disease
    Author: Alexandra Kutzelnigg

  3. P35.06: A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: feasibility and safety
    Author: Merrill Landers

  4. P35.09: Does Outpatient Palliative Care Improve Patient Centered Outcomes in Parkinson’s Disease: Study Protocol for a Multi-Center Randomized Controlled Trial
    Author: Janis Miyasaki

  5. P35.20: Results of a phase 3 efficacy and safety study of ADS-5102 (amantadine HCl) extended-release capsules in Parkinson’s disease patients with levodopa-induced dyskinesia (EASE LID 3)
    Author: Mary Jean Stempien

  6. LBP32: Inhibition of glucosylceramide synthase alleviates aberrations in synucleinopathy models: Link to GBA-related Parkinson's disease
    Author: S. Pablo Sardi

Tour #21

Guide: Joe Quinn


  1. P12.07: C.o.p.e.-care optimally Parkinson education for caregivers, a small group education and support group for new caregivers and care partners
    Author: Anissa Mitchell

  2. P34.07: Higher mortality with antipsychotic medication use in individuals with Parkinson’s disease
    Author: Peter Schmidt

  3. P35.07: A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: signal of efficacy
    Author: Merrill Landers

  4. P35.24: Multi-system balance training programme enhances comprehensive balance and functional performance in Parkinsonian non-fallers: a randomized controlled trial with one-year follow-up
    Author: Irene S. Wong-Yu

  5. P42.01: A service evaluation by Parkinson’s disease nurse specialists, of Parkinson’s Kinetigraph (PKG) movement recording system use in routine clinical care of patients with Parkinson’s disease
    Author: Jane Price

  6. P42.02: Parkinson's Community Transforming Service Delivery - The UK Parkinson's Excellence Model
    Author: Val Buxton

Tour #22

Guide: Simon Lewis


  1. P34.04: Technology utilization and preferences among people with Parkinson's
    Author: John Dean

  2. P37.02: Beta testing with Parkinson’s patients for a mobile research study
    Author: Margaret Daeschler (presented by Chen Admati)

  3. P37.03: Building Parkinson's communities of support in virtual worlds
    Author: Donna Davis

  4. P37.12: Alleviating Freezing of Gait in Parkinson’s disease: open-loop external cues versus closed-loop biofeedback
    Author: Martina Mancini

  5. P37.18: Feasibility of long-term deployment of wearable sensors in Parkinson’s disease: the Parkinson@home study
    Author: Ana Lígia Silva de Lima

Tour #23

Guide: A. Jon Stoessl


  1. P30.01: Ultra High Field MRI of Nigrosome 1 is a Biomarker of New Onset and Premotor Parkinson’s Disease
    Author: Matthew Brodsky

  2. P30.03: Prescribed Gait Tests versus Continuous Monitoring of Gait in People with Parkinson’s Disease
    Author: Carolin Curtze

  3. P30.04: Biomarkers of Catecholaminergic Neurodegeneration Predict Parkinson’s Disease: A First Look at the NINDS PDRisk Study
    Author: David Goldstein

  4. P30.05: Denervation-Dependent and -Independent Abnormalities of Central Dopamine Metabolism in Parkinsonism
    Author: David Goldstein

  5. P30.08: Diurnal fluctuations of Inflammatory Factors in CSF and Serum and Identification of Inflammatory Markers that can be used to Discriminate between Parkinson’s Disease and Age-matched Healthy Controls
    Author: George Kannarkat

  6. P30.14: Tau imaging in atypical parkinsonism. Preliminary evidence with [11C]PBB3 PET in atypical Parkinsonisms.
    Author: Alexandra Perez Soriano

  7. P30.16: Investigation of exercise vs. repetitive transcranial magnetic stimulation induced dopamine release: [11C]Raclopride PET study
    Author: Matthew Sacheli

Tour #24

Guide: Beth-Anne Sieber


  1. P31.10: Istradefylline and Preladenant as an adjuvant therapies for Patients with Parkinson’s disease
    Author: Ahmed Negida

  2. P31.18: ND0701: A novel safe concentrated apomorphine formulation for continuous subcutaneous administration via a patch pump
    Author: Ronit Shaltiel-Karyo

  3. P31.19: Effects of levodopa-carbidopa intestinal gel on non-motor symptoms and safety of outpatient titration: a phase 3 study in advanced Parkinson’s disease patients
    Author: David Standaert

  4. P31.20: Baseline characteristics associated with therapeutic response to levodopa-carbidopa intestinal gel treatment for advanced Parkinson disease
    Author: David Standert

  5. P31.24: Integrated analysis of droxidopa for the treatment of neurogenic orthostatic hypotension in patients with Parkinson’s disease
    Author: Art Hewitt

  6. LBP25: Effects of age and disease duration on quality of life outcomes in advanced Parkinson’s disease patients treated with levodopa-carbidopa intestinal gel infusions: a post-hoc analysis from the GLORIA registry
    Author: Lars Bergmann

Tour #25

Guide: Robin Elliott


  1. P38.02: 444 Parkinson’s Traveler:  Example Impact of a Personal Parkinson’s Awareness Campaign
    Author: Marcus Cranston

  2. P38.11: Community-based Alexander Technique programming designed and delivered by Parkinson's patient
    Author: Paul Recker

  3. P38.14: This is Parkinson’s disease: an awareness campaign promoting the diversity of the diagnosed
    Author: Alicia Wrobel

  4. P39.02: Advocacy is Education – Developing support for a provincial Parkinson’s disease strategy in British Columbia
    Author: Kristen Sundvick

  5. P41.02: The Parkinson’s UK Research Support Network (RSN) - collaborating for a cure
    Author: Richard Windle

  6. P41.03: A new volunteer-led method for looking at drug repurposing
    Author: Richard Windle

  7. LBP34: In Case of Adverse Events:  Just Compensation for US Human Volunteers Injured in Clinical Trials
    Author: Jean Burns




Membership Software Powered by®  ::  Legal